Biogen Shares DEVOTE and RESPOND Study Updates

Biogen recently shared that they have completed enrollment in the global DEVOTE and RESPOND clinical studies.

Check out the full SMA Community Statement here.


Do you like what you're reading?

Help make a difference in the lives of people affected by spinal muscular atrophy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top